Document Type

Journal Article

Publication Title

Psychiatry Research

ISSN

1872-7123

Volume

273

First Page

75

Last Page

81

PubMed ID

30640054

Publisher

Elsevier/North-Holland Biomedical Press

School

School of Medical and Health Sciences/ Global Health and Genomics

RAS ID

28590

Comments

This is an Author's Accepted Manuscript of: Li, H., Wang, A., Qi, G., Guo, J., Li, X., Wang, W., . . . Guo, X. (2019). Cystatin C and risk of new-onset depressive symptoms among individuals with a normal creatinine-based estimated glomerular filtration rate: A prospective cohort study. Psychiatry Research, 273, 75-81. Original article available here

© 2019. This manuscript version is made available under the CC-BY-NC-ND 4.0 license http://creativecommons.org/licenses/by-nc-nd/4.0/

Abstract

The association between cystatin C and depressive symptoms in the general population has not been thoroughly elucidated to date. We investigated the association of cystatin C with new-onset depressive symptoms among individuals with normal creatinine-based estimated glomerular filtration rates (eGFR). In the China Health and Retirement Longitudinal Study, 5111 participants without depressive symptoms or renal dysfunction (eGFR < 60 ml/min/1.73 m

DOI

10.1016/j.psychres.2019.01.009

Available for download on Tuesday, March 03, 2020

Included in

Nephrology Commons

Share

 
COinS